Linda Mah

Linda Mah, MD, MHSc, FRCPC, is a Canadian Clinician Scientist at the Rotman Research Institute, Baycrest Health Sciences, an Associate Professor in Psychiatry, Division of Geriatric Psychiatry at the University of Toronto, and an Associate Member of the Institute of Medical Science, Faculty of Medicine, University of Toronto.¹⁾

She is notable in the COVID-19 pandemic for her role on the Ontario COVID-19 Science Advisory Table.

Dr. Mah obtained her MD at the University of Calgary and completed a psychiatric residency at McGill University, followed by clinical neuropsychiatry specialty training at the University of Massachusetts and formal research training in cognitive and affective neurosciences at the National Institutes of Health, Bethesda, Maryland, USA. She has a Master of Health Sciences degree from Duke University, USA, where she attended from 2003-2006.^{2) 3)}

In 1998 - 1999, Mah worked as a member of the Fellowships and Awards Committee of the Academy of Consultation-Liaison Psychiatry (also known as the Academy of Psychosomatic Medicine) in Bathesda, Maryland.⁴⁾

Mah is a Clinician Scientist at the Rotman Research Institute at Baycrest Health Sciences in the North York district of Toronto, Ontario.⁵⁾ She is also a Staff Psychiatrist at Baycrest.⁶⁾

In 1996 - 1997, Mah served as Corresponding Member of the Efficacy and Cost-effectiveness Working Group, Steering Committee on the Psychotherapies for the Canadian Psychiatric Association.

Mah also acted as a Staff Psychiatrist in the Adult Neurodevelopment and Geriatric Psychiatry Division at the Centre for Addiction and Mental Health (CAMH).⁷⁾

Mah worked as a Staff Physician at the Warren Grant Magnuson Clinical Center under the National Institutes of Health in Bathesda, Maryland from 2000-2006.⁸⁾

She received a Fellows Award for Research Excellence from the National Institute of Mental Health in 2005.

Mah is a member of the Ontario COVID-19 Science Advisory Table, and a Co-Chair of the Mental Health Working Group.⁹⁾

From September 1987 until April 1988, Mah worked as a part-time research assistant in the Department of Psychology at the University of Waterloo under Dr. Kathleen Bloom. She returned in May 1991 to complete three further months of research funded by the Natural Sciences and Engineering Research Council of Canada (NSERC), under Dr. Phil Bryden.¹⁰⁾

Mah is an Associate Professor in Psychiatry, Division of Geriatric Psychiatry at the University of Toronto, and an Associate Member of the Institute of Medical Science, Faculty of Medicine, University of Toronto.¹¹⁾ She received $150,000.00 as an Academic Scholar Award from the Department of Psychiatry in 2018.¹²⁾

In her curriculum vitae, Mah describes having worked as a Staff Psychiatrist at the Worcester State Hospital in Worcester, Massachusetts from 1999-2000.¹³⁾

Man is a member of various societies and associations relevant to her field.¹⁴⁾

Dr. Mah’s research program focuses on understanding the relationship between cognition and emotion and their neuroanatomical correlates in healthy aging and in disorders of the elderly, including late-life depression (LLD), mild cognitive impairment (MCI), and Alzheimer’s disease (AD).

Her research employs converging methods including behavioural paradigms, neuropsychological assessment, neuroimaging, and more recently, psychophysiology. She has a particular interest in examining emotion dysregulation and other neuropsychiatric symptoms as potential biomarkers of AD risk, and in understanding the link between stress and development of AD.

Dr. Mah is also the primary investigator (or site investigator) on clinical trials focused on treatment-refractory depression in older adults and studies using brain stimulation as an intervention for cognitive decline in older adults at risk for developing AD, including those with remitted depression, subjective cognitive decline (SCD) or MCI.

She is an Associate Editor for the Journal of Alzheimer’s Disease.¹⁵⁾

Mah took part in joint research with Baycrest Health Sciences's Rotman Research Institute and the Centre for Addiction and Mental Health (CAMH) studying the impact of COVID-19 and physical distancing measures on older adults' mental health, funded by the Ontario Ministry of Health and Long-Term Care Academic Health Science Centre (AHSC) Alternative Funding Plan (AFP) Innovation Fund.¹⁶⁾

Dr. Mah’s work has been primarily funded by the Alzheimer’s Society of Canada, Brain Canada, and the Centre for Aging and Brain Health Innovation.¹⁷⁾ Further research funding has come from the National Institute of Mental Health and The Scottish Rite Charitable Foundation.^{18) 19)}